<DOC>
	<DOC>NCT01773096</DOC>
	<brief_summary>The purpose of this study is to determine whether the routine use of methylnaltrexone in the post-operative pediatric spinal fusion patient will decrease the incidence of constipation.</brief_summary>
	<brief_title>Methylnaltrexone Use for Opioid-induced Postoperative Constipation</brief_title>
	<detailed_description>Methylnaltrexone will be given to pediatric patients post-operative from spinal fusion surgery on post-operative day number 3 and then again on postoperative day number 4, if no laxation achieved. Various outcome measures, safety and efficacy of the drug will be observed and recorded.</detailed_description>
	<mesh_term>Constipation</mesh_term>
	<mesh_term>Analgesics, Opioid</mesh_term>
	<mesh_term>Bismuth subsalicylate</mesh_term>
	<mesh_term>Polyethylene glycol 3350</mesh_term>
	<mesh_term>Bisacodyl</mesh_term>
	<mesh_term>Magnesium Hydroxide</mesh_term>
	<mesh_term>Methylnaltrexone</mesh_term>
	<mesh_term>Naltrexone</mesh_term>
	<criteria>spinal fusion surgery current opioid use 12 years of age and older no or inadequate bowel movement by postoperative day 3 known or expected mechanical bowel obstruction known or suspected lesions of the GI tract unexpected transfer to ICU unexpected return to the operating room patient or parent refusal of methylnaltrexone incomplete data concerning time to laxation</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>21 Years</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>opioid-induced</keyword>
</DOC>